an oncology company, which focused on developing novel targeted therapies and engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment.
Industry Biotechnology
A.I.dvisor indicates that over the last year, RVMD has been loosely correlated with ROIV. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if RVMD jumps, then ROIV could also see price increases.
Ticker / NAME | Correlation To RVMD | 1D Price Change % | ||
---|---|---|---|---|
RVMD | 100% | -2.51% | ||
ROIV - RVMD | 39% Loosely correlated | -3.76% | ||
RARE - RVMD | 37% Loosely correlated | -1.88% | ||
CHRS - RVMD | 35% Loosely correlated | -2.16% | ||
IMTX - RVMD | 35% Loosely correlated | -0.36% | ||
ALLO - RVMD | 34% Loosely correlated | -4.56% | ||
More |